Climb Bio Inc (CLYM) - News Archive

Showing 2 of 2 results.

Climb Bio Ascends Innovating IgAN Treatment While Bolstering Financial Resilience,

Navigating Breakthroughs: Climb Bio s Strategic Advances in IgA Nephropathy Treatment Climb Bio Inc. is poised to make an impressive mark at the forthcoming American Society of Nephrology (ASN) Kidney Week 2025. The com...

Oct 20, 2025 • Major Pharmaceutical Preparations Industry Clinical Study Inc

Climb Bio to Unveil Strategic Focus on Immune-Mediated Diseases and Budoprutug Development in Virtual Investor Update,

IntroductionClimb Bio, a biopharmaceutical company, is preparing to share significant updates regarding its lead product candidate, Budoprutug, and its strategic focus on immune-mediated diseases during an upcoming virt...

Oct 15, 2024 Management Announcement